0 followers
To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.
Industries
Headquarters
Stage
Employees
Links
View full screen
Giuseppe Mazza
View all
12 members
2 members
1 members
Fios Genomics
3 followers
Coherus BioSciences
5 followers
Sano Genetics
2 followers
evonetix
1 follower
Autolomous
Explore more companies